Richard Klemke
Company: Cytonus Therapeutics
Job title: Founder & Chief Scientific Officer
Seminars:
Employing Enucleated Cell Carriers as Delivery Systems to Improve Targeted Cancer Vaccine Delivery for More Successful Therapies 3:15 pm
Overcoming the blood barrier using enucleated mesenchymal stromal cells that can migrate into the tumor environment for targeted personalized cancer vaccine delivery Utilizing mRNA and cell-penetrating peptides as vaccine modalities to efficiently target the cancer tumor Amplifying the targeted effect of enucleated cell carriers by cargo sites to specifically deliver the cancer vaccine for the…Read more
day: Conference Day Two